Literature DB >> 16261527

Amelioration of non-alcoholic steatohepatitis and glucose intolerance in ob/ob mice by oral immune regulation towards liver-extracted proteins is associated with elevated intrahepatic NKT lymphocytes and serum IL-10 levels.

Eran Elinav1, Orit Pappo, Miriam Sklair-Levy, Maya Margalit, Oren Shibolet, Moshe Gomori, Roslana Alper, Barbara Thalenfeld, Dean Engelhardt, Elazar Rabbani, Yaron Ilan.   

Abstract

Non-alcoholic steatohepatitis (NASH) is a common cause of cryptogenic cirrhosis in the Western world. In an animal model of NASH, leptin-deficient ob/ob mice present with alterations in number and function of hepatic NKT and peripheral CD4 lymphocytes. Oral immune regulation is a method to alter the immune response towards orally administered antigens. To determine the effect of oral immune regulation towards liver-extracted proteins on the metabolic disorders in ob/ob mice, ob/ob mice and their lean littermates were orally administered liver extracts from wild-type or ob/ob mice or bovine serum albumin for 1 month. The effect of treatment on hepatic fat content was measured by magnetic resonance imaging (MRI) and using a histological steatohepatitis grading scale. Glucose tolerance was measured by an oral glucose tolerance test (GTT). T lymphocyte subpopulations were assessed by flow cytometry analysis. Induction of immune regulation by oral presentation of liver-extracted proteins resulted in a significant 18% reduction of the hepatic fat content in ob/ob mice fed with either wild-type or ob/ob liver extracts for 1 month. The MRI signal intensity index in treated mice decreased to 0.48 and 0.51, respectively, compared with 0.62 in BSA-fed controls (p = 0.037 and p = 0.019, respectively), while the histological steatohepatitis score decreased in both treated groups to 2.0, compared with 2.4 in BSA-fed controls (p = 0.05). A significant improvement in GTT was noted in treated ob/ob mice. These changes were accompanied by a marked increase in the intrahepatic NKT lymphocyte population in mice fed with proteins extracted from both wild-type and ob/ob mice (46.96% and 56.72%, respectively, compared with 26.21% in BSA-fed controls; p < 0.05) and a significant elevation in serum IL-10 levels. Oral immune regulation towards liver extracted proteins in leptin-deficient mice resulted in a marked reduction in hepatic fat content and improved glucose tolerance. This effect was associated with a significant increase in the intrahepatic NKT lymphocyte population and serum IL-10 levels, suggesting a Th1 to Th2 immune shift. Immune regulation towards disease-associated antigens holds promise as a new mode of therapy for NASH. Copyright 2005 Pathological Society of Great Britain and Ireland.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16261527     DOI: 10.1002/path.1869

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  16 in total

1.  Pro- and anti-inflammatory cytokines in steatosis and steatohepatitis.

Authors:  Fabiola Rabelo; Claudia P M S Oliveira; Joel Faintuch; Daniel F C Mazo; Vicencia M R Lima; Jose Tadeu Stefano; Hermes V Barbeiro; Francisco G Soriano; Venancio A Ferreira Alves; Flair J Carrilho
Journal:  Obes Surg       Date:  2010-07       Impact factor: 4.129

2.  Association of the frequency of peripheral natural killer T cells with nonalcoholic fatty liver disease.

Authors:  Cheng-Fu Xu; Chao-Hui Yu; You-Ming Li; Lei Xu; Juan Du; Zhe Shen
Journal:  World J Gastroenterol       Date:  2007-09-07       Impact factor: 5.742

3.  Thymoquinone alleviates nonalcoholic fatty liver disease in rats via suppression of oxidative stress, inflammation, apoptosis.

Authors:  Azza S M Awad; Ekram N Abd Al Haleem; Wesam M El-Bakly; Mohie A Sherief
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-01-12       Impact factor: 3.000

Review 4.  Adipose invariant natural killer T cells.

Authors:  Lydia Lynch
Journal:  Immunology       Date:  2014-07       Impact factor: 7.397

Review 5.  Beyond insulin resistance: Innate immunity in nonalcoholic steatohepatitis.

Authors:  Jacquelyn J Maher; Pablo Leon; James C Ryan
Journal:  Hepatology       Date:  2008-08       Impact factor: 17.425

6.  Probiotics improve high fat diet-induced hepatic steatosis and insulin resistance by increasing hepatic NKT cells.

Authors:  Xiong Ma; Jing Hua; Zhiping Li
Journal:  J Hepatol       Date:  2008-06-30       Impact factor: 25.083

7.  Probiotics restore bowel flora and improve liver enzymes in human alcohol-induced liver injury: a pilot study.

Authors:  Irina A Kirpich; Natalia V Solovieva; Svetlana N Leikhter; Natalia A Shidakova; Oxsana V Lebedeva; Pavel I Sidorov; Tatjana A Bazhukova; Andrej G Soloviev; Shirish S Barve; Craig J McClain; Matt Cave
Journal:  Alcohol       Date:  2008-12       Impact factor: 2.405

8.  Personalized inherent randomness of the immune system is manifested by an individualized response to immune triggers and immunomodulatory therapies: a novel platform for designing personalized immunotherapies.

Authors:  Madi El-Haj; Dimitri Kanovitch; Yaron Ilan
Journal:  Immunol Res       Date:  2019-10       Impact factor: 2.829

9.  Liver fibrogenesis in non-alcoholic steatohepatitis.

Authors:  Zhaolian Bian; Xiong Ma
Journal:  Front Physiol       Date:  2012-07-11       Impact factor: 4.566

10.  Hepatic expression patterns of inflammatory and immune response genes associated with obesity and NASH in morbidly obese patients.

Authors:  Adeline Bertola; Stéphanie Bonnafous; Rodolphe Anty; Stéphanie Patouraux; Marie-Christine Saint-Paul; Antonio Iannelli; Jean Gugenheim; Jonathan Barr; José M Mato; Yannick Le Marchand-Brustel; Albert Tran; Philippe Gual
Journal:  PLoS One       Date:  2010-10-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.